 Cholesterol, VLDL
"Cholesterol, VLDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL.
| Descriptor ID |
D015243
|
| MeSH Number(s) |
D04.210.500.247.808.197.247 D10.532.599.700 D10.570.938.208.285 D12.776.521.622.700
|
| Concept/Terms |
Cholesterol, VLDL- Cholesterol, VLDL
- VLDL Cholesterol
- Pre-beta-Lipoprotein Cholesterol
- Cholesterol, Pre-beta-Lipoprotein
- Pre beta Lipoprotein Cholesterol
- Very Low Density Lipoprotein Cholesterol
- Prebetalipoprotein Cholesterol
- Cholesterol, Prebetalipoprotein
|
Below are MeSH descriptors whose meaning is more general than "Cholesterol, VLDL".
Below are MeSH descriptors whose meaning is more specific than "Cholesterol, VLDL".
This graph shows the total number of publications written about "Cholesterol, VLDL" by people in this website by year, and whether "Cholesterol, VLDL" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2008 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholesterol, VLDL" by people in Profiles.
-
Shewale SV, Boudyguina E, Zhu X, Shen L, Hutchins PM, Barkley RM, Murphy RC, Parks JS. Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver. J Lipid Res. 2015 Jun; 56(6):1191-205.
-
Eckel RH. What is it about very low density lipoproteins (VLDL) and cardiovascular disease in patients with type 2 diabetes mellitus: is it the triglycerides or the cholesterol? Atherosclerosis. 2014 Nov; 237(1):138-9.
-
B?rsheim E, Bui QU, Tissier S, Cree MG, R?nsen O, Morio B, Ferrando AA, Kobayashi H, Newcomer BR, Wolfe RR. Amino acid supplementation decreases plasma and liver triacylglycerols in elderly. Nutrition. 2009 Mar; 25(3):281-8.
-
Brennan FX, Grahn RE, Watkins LR, Maier SF. Serum cholesterol levels and stressor controllability in rats. Physiol Behav. 2003 Sep; 79(4-5):757-60.
-
MacLean PS, Bower JF, Vadlamudi S, Osborne JN, Bradfield JF, Burden HW, Bensch WH, Kauffman RF, Barakat HA. Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice. Arterioscler Thromb Vasc Biol. 2003 Aug 01; 23(8):1412-5.
-
Haffner SM, D'Agostino R, Mykk?nen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999 Apr; 22(4):562-8.
-
Kliem V, Wanner C, Eisenhauer T, Olbricht CJ, Doll R, Boddaert M, O'Grady P, Krekler M, Mangold B, Christians U. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine. Transplant Proc. 1996 Dec; 28(6):3126-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|